For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ('Profound” or the 'Company”), a commercial-stage innovator in interventional ...

New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...

The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...

You are at the center of everything we do at the Prostate Oncology Center at Fred Hutchinson Cancer Center. Here, we surround you with a team of specialists who work together closely to provide expert ...

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now ...

Add Yahoo as a preferred source to see more of our stories on Google. Joe Biden's Cancer Moonshot initiative had funded hundreds of cancer research projects across the country. AP Photo/Gerald Herbert ...

Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...

New research shows that vegetables and probiotics may help to stabilise or retard tumour growth in the prostate.